A NEW DRUG TRIALS SNAPSHOT FOR EUCRISA is now available.
EUCRISA is a drug for treatment of mild to moderate atopic dermatitis in patients 2 years of age and older.
Atopic dermatitis is an inflammatory skin disease that occurs primarily in children and younger adults.
Drug Trials Snapshots provide information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.